Mesenchymal–Epithelial Transition Factor Immunoreactivity in Positive Sentinel Nodes From Patients With Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanoma
Ann Diagn Pathol 2022 Jun 01;58(xx)151909, EEAP Mulder, D Verver, T van der Klok, CJ de Wijs, TPP van den Bosch, MJ De Herdt, B van der Steen, C Verhoef, AAM van der Veldt, DJ Grünhagen, S KoljenovicFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.